C22 Glucosylceramide (d18:1/22:0)-d 4

Overview

C22 Glucosylceramide (d18:1/22:0) -d 4 is deuterium labeled C22 Glucosylceramide (d18:1/22:0) ( HY-164236 ). C22 Glucosylceramide (d18:1/22:0) is a bioactive sphingolipid composed of a d18:1 sphingoid base and a 22:0 fatty acid chain. C22 Glucosylceramide (d18:1/22:0) specifically exists in Doxorubicin ( HY-15142A )-sensitive cancer cells, and its circulating concentration is positively correlated with the incidence of cardiovascular events. C22 Glucosylceramide (d18:1/22:0) has been widely used in research related to cardiovascular diseases, hypercholesterolemia, metabolic syndrome, breast adenocarcinoma and other fields.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-164236S
• CAS No.: 2738376-81-1
• Molecular Formula: C46H85D4NO8
• Molecular Weight: 788.23
• Purity: 98%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source